Skip to content

The efficacy and mechanism of personalized theta burst mode magnetic stimulation in the treatment of post-stroke cognitive impairment

The efficacy and mechanism of personalized theta burst mode magnetic stimulation in the treatment of post-stroke cognitive impairment

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068070
Enrollment
Unknown
Registered
2023-02-06
Start date
2023-02-06
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke cognitive impairment

Interventions

Low-dose intervention group :Low-dose iTBS+conventional rehabilitation
High-dose intervention group:High-dose iTBS+conventional rehabilitation
sham group:sham iTBS+conventional rehabilitation

Sponsors

china rehabilitation research center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 35 to 75 years. 2. First stroke, duration of illness 4 weeks to 12 months. 3. Stroke site located on the cerebral curtain. 4. right sharp hand. 5. stable vital signs and no progressive neurological symptoms. 6. meeting the diagnostic criteria in the Expert Consensus on Management of Cognitive Impairment after Stroke 2021, with the following conditions being met: (1) dysfunction in at least one of the following 5 areas: executive function, attention, memory, language ability, and visuospatial ability; (2) ability to cooperate in completing MoCA with a MoCA score = 10. 7. Meeting the diagnostic criteria for stroke in the Diagnostic Essentials of Various Major Cerebrovascular Diseases in China 2019. 8. Patients or family members were informed of the examination and treatment procedures of this study.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to TMS or fMRI, such as intracranial metal, epilepsy, etc. 2. History of drug or alcohol dependence, other psychiatric disorders, or current comorbid major depression/anxiety disorder. 3. Significant cognitive dysfunction prior to stroke. 4. Patients with a combination of severe aphasia, visual and hearing impairment, unstable arrhythmias or other serious physical conditions that prevent them from cooperating with the completion of cognitive assessment or treatment. 5. No previous rTMS intervention within 6 months prior to receiving treatment. 6. Women who are pregnant. 7. Patients are participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Montreal cognitive assessment scale;

Secondary

MeasureTime frame
Mini-mental state assessment scale;Wechsler adult intelligence scale;Wechsler Memory Scale;

Countries

China

Contacts

Public ContactZhang Hao

China rehabilitation research center

zh1665@163.com+86 137 0135 6685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026